What it actually costs to treat a malnourished child

The phrase “child malnutrition” covers at least three medically distinct conditions, and the difference matters enormously to what a donation can buy. Wasting is acute: a child has lost weight rapidly relative to their height and is at immediate risk. Stunting is chronic: a child is shorter than they should be for their age because of prolonged inadequate nutrition, usually beginning before birth. Micronutrient deficiency can exist independently of either, in children whose weight looks unremarkable.

Only the first of these can be reversed in weeks. Stunting after roughly the first two years is largely irreversible, which is why prevention programmes target pregnancy and infancy rather than school age. When a fundraising appeal shows a visibly thin child and asks for money to “end malnutrition”, it is showing you wasting and promising you something closer to stunting prevention. Those are not the same product.

How a child is actually identified as malnourished

Diagnosis in field conditions is deliberately simple, because it has to work in a village with no electricity and a health worker with two hours of training. The primary tool is a MUAC tape: a strip of plastic wrapped around the mid-upper arm, colour-coded rather than numbered, so that the reading requires no arithmetic.

The oedema check matters and is frequently omitted in donor-facing explanations. A child with nutritional oedema retains fluid, so they can weigh more than a healthier child while being in greater danger. Weight alone would classify them as fine. This is one reason screening is a protocol rather than a scale.

What therapeutic food is and why it is shaped the way it is

Ready-to-use therapeutic food, universally abbreviated to RUTF, is a peanut-based paste fortified with milk powder, oil, sugar, vitamins and minerals. A standard sachet weighs about 92 grams and delivers roughly 500 kilocalories along with a full micronutrient profile.

Three design decisions explain almost everything about its cost and its usefulness. It contains very little water, so bacteria cannot grow in it and it needs no refrigeration or clean water to prepare. It is eaten directly from the sachet, so it does not require cooking fuel, utensils or a mother’s time. And it is energy-dense enough that a small child can consume a therapeutic dose without needing a large appetite.

Those properties are what allow treatment to happen at home. Before RUTF, severe acute malnutrition was treated with therapeutic milk in a hospital, which meant a caregiver had to leave their other children and their livelihood for weeks. Outpatient treatment raised coverage dramatically, and it is the reason a donation can be measured in sachets at all.

The bill, broken into the parts nobody puts on a fundraising banner

The figures below are indicative ranges rather than quotations. They shift with commodity prices, tender volume, currency movements, security conditions and how far the last mile actually is. Treat them as a way to interrogate a cost claim, not as a price list.

The practical consequence is that two organisations can both be honest and still publish cost-per-child figures that differ by a factor of three. One may be quoting the commodity cost of the food and nothing else; the other may be quoting fully delivered cost including staff and follow-up. Neither is lying. Only one is comparable to a competing figure.

What success looks like, in numbers a donor can check

Nutrition programmes are unusually measurable, and the sector has agreed benchmarks. The Sphere minimum standards set a recovery rate above 75 per cent for therapeutic feeding programmes, with death rates and default rates kept below defined thresholds. A programme reporting against those categories is telling you something falsifiable.

Standard treatment length

6–8 weeks

Sachets per course

~100–150

Energy per sachet

~500 kcal

Sphere recovery benchmark

>75%

The three numbers that matter more than “children reached”

• Cure rate: the share of admitted children who reach discharge criteria. High is good, but suspiciously high can mean the programme is admitting children who were not severely malnourished.
• Default rate: the share who stop attending before discharge. This is the honest measure of whether a programme is actually reachable for the families it serves — long distances and hidden costs show up here first.
• Relapse: children readmitted within a few months. A programme with excellent cure rates and high relapse is treating episodes rather than causes, which is worth knowing before you fund it as a permanent solution.

“Children reached” is the weakest of the common metrics because it counts contact rather than outcome. A screening round that measures ten thousand arms has reached ten thousand children, and may have treated none of them.

Why the same donation buys less in July than in January

In much of the Sahel and East Africa, admissions follow a predictable annual curve. The lean season — the months between the exhaustion of last year’s harvest and the arrival of the next — pushes caseloads up sharply, and it frequently coincides with the rains that make roads impassable. Costs rise exactly when need rises.

This has a direct implication for donors that almost nobody mentions: money committed early is worth more than money donated at the peak. Stock pre-positioned before the roads close is cheaper to move and available when the caseload arrives. Emergency appeals raised during the peak are, by construction, buying at the worst moment of the year.

Predictable crises funded unpredictably is the most expensive way to run humanitarian nutrition, and it is close to the default.

A recurring theme in evaluations of lean-season response

How this shapes what we fund

HopePlates concentrates on child malnutrition relief and therapeutic nutrition, and we try to describe purchases in units that can be checked: cartons ordered, supplier, destination, date. When we publish a spent total on the transparency page, the intention is that it maps onto procurement rather than onto a category label.

We are also deliberately cautious about the cost-per-child framing. It is a useful shorthand and a misleading promise. A donation buys inputs with a known price; whether a specific child recovers depends on infection, on distance, on whether a caregiver can make six follow-up visits, and on many things no donor controls. We would rather show you the inputs we bought than a survival claim we cannot substantiate.